New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Brenzavvy bexagliflozin Click here for more information |
TheracosBio | A new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. |
|
Daybue trofinetide Click here for more information |
Acadia Pharm | A new medication for the treatment of Rett syndrome (unknown mechanism). |
|
Elfabrio pegunigalsidase alfa-iwxj For more information click here |
Chiesi USA | A new hydrolytic lysosomal neutral glycosphingolipid-specific enzyme for Fabry disease. |
|
Epkinly epcoritamab-bysp For more information click here |
Genmab US | A new bispecific CD20-directed CD3 T-cell engager for diffuse large B-cell lymphoma. |
|
Filspari sparsentan Click here for more information |
Travere Therapeutics | A new endothelin and angiotensin II receptor antagonist to reduce proteinuria in adults. |
|
Inpefa sotagliflozin Click here for more information |
Lexicon | A new sodium-glucose cotransporter 2 (SGLT2) inhibitor to reduce cardiovascular death, heart failure-related hospitalization, and urgent heart failure visits. |
|
Jaypirca pirtobrutinib Click here for more information |
Eli Lilly | A new kinase inhibitor for the treatment of mantle cell lymphoma (MCL). |
|
Jesduvroq daprodustat Click here for more information |
GlaxoSmithKline | A new oral hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor for the treatment of anemia in patients with chronic kidney disease receiving dialysis. |
|
Joenja Leniolisib Click here for more information |
Pharming Healthcare | A new kinase inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS). |
|
Lamzede velmanase alfa-tycv Click here for more information |
Chiesi USA | A new recombinant human lysosomal alpha-mannosidase for the treatment of non-central nervous system manifestations of alpha-mannosidiosis. |
|
Leqembi lecanemab-irmb Click here for more information |
Eisai | A new amyloid beta-directed antibody for the treatment of Alzheimer’s disease. |
|
Miebo perfluorohexyloctane Click here for more information |
Bausch & Lomb | A new semifluorinated alkane for dry eye disease (unknown mechanism). |
|
Orserdu elacestrant Click here for more information |
Stemline Therapeutics | A new estrogen receptor antagonist for the treatment of breast cancer. |
|
Paxlovid nirmatrelvir/ritonavir For more information click here |
Pfizer | A new antiviral for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (previously available through an emergency use authorization [EUA]). |
|
Qalsody tofersen Click here for more information |
Biogen | A new antisense oligonucleotide for the treatment of amyotrophic lateral sclerosis (ALS). |
|
Rezzayo rezafungin Click here for more information |
Melinta Therapeutics | A new echinocandin antifungal for the treatment of candidemia and invasive candidiasis. |
|
Skyclarys omaveloxolone Click here for more information |
Reata Pharmaceuticals | A new treatment of Friedreich’s ataxia (unknown mechanism). |
|
Veozah fezolinetant For more information click here |
Astellas Pharma | A new neurokinin 3 (NK3) receptor antagonist for vasomotor menopausal symptoms. |
|
Xacduro sulbactam/durlobactam For more information click here |
Astellas Pharma | A new beta-lactam/beta-lactam inhibitor antibiotic for hospital-acquired or ventilator-associated bacterial pneumonia. |
|
Yuflyma adalimumab-aaty Click here for more information |
Celltrion USA | A new biosimilar to Humira. |
|
Zavzpret zavegepant Click here for more information |
Pfizer | A new calcitonin gene-related peptide (CGRP) receptor antagonist for treatment of acute migraine in adults. |
|
Zejula niraparib Click here for more information |
GlaxoSmithKline | A new poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of ovarian, fallopian tube, or peritoneal cancers. |
|
Zynyz retifanlimab Click here for more information |
Incyte | A new programmed death receptor-1 (PD-1) blocking antibody for the treatment of Merkel cell carcinoma. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Abilify Asimtufii aripiprazole Click here for more information |
Otsuka America | A new extended-release injectable suspension for schizophrenia and bipolar 1 disorder. |
|
Airsupra albuterol/budesonide Click here for more information |
AstraZeneca | A new combination metered-dose inhaler for the treatment of asthma. |
|
Atorvaliq atorvastatin Click here for more information |
CMP Pharma | A new oral suspension to lower cholesterol. |
|
Combogesic acetaminophen/ ibuprofen Click here for more information |
AFT Pharm | A new combination product for the treatment of mild to moderate acute pain. |
|
Liqrev sildenafil Click here for more information |
CMP Pharma | A new oral suspension for pulmonary arterial hypertension (PAH). |
|
Lumryz sodium oxybate Click here for more information |
Avadel CNS Pharmaceuticals | A new extended-release powder for oral suspension for the treatment of narcolepsy. |
|
Mekinist trametinib Click here for more information |
Novartis | A new oral solution for unresectable or metastatic melanoma. |
|
Motpoly XR lacosamide Click here for more information |
Aucta Pharmaceuticals | A new extended-release capsule for partial-onset seizures. |
|
Opvee nalmefene For more information click here |
Opiant | A new nasal spray for known or suspected opioid overdose. |
|
Prevduo neostigmine/glycopyrrolate Click here for more information |
Slayback Pharma | A new fixed-dose combination to reverse the effects of non-depolarizing neuromuscular blocking agents after surgery. |
|
Rizafilm rizatriptan Click here for more information |
IntelGenX | A new oral film for the treatment of acute migraine with or without aura. |
|
Rykindo risperidone Click here for more information |
Shandong Luye Pharm | A new long-acting injectable for schizophrenia and bipolar disorder. |
|
Syfovre pegcetacoplan Click here for more information |
Apellis Pharm | A new injection for intravitreal use to treat geographic atrophy secondary to age-related macular degeneration. |
|
Symbicort Aerosphere budesonide/formoterol Click here for more information |
AstraZeneca | A new pressurized metered-dose inhaler for chronic obstructive pulmonary disease (COPD). |
|
Tafinlar dabrafenib Click here for more information |
Novartis | A new tablet for oral suspension for unresectable or metastatic melanoma. |
|
Trikafta elexacaftor/tezacaftor/ivacaftor Click here for more information |
Vertex Pharmaceuticals | A new fixed-dose combination tablet co-packaged with ivacaftor tablets for cystic fibrosis (CF). |
|
Uzedy risperidone Click here for more information |
Teva Pharmaceuticals | A new extended-release injectable suspension for schizophrenia |
|
Vevye cyclosporine For more information click here |
Novaliq | A new 0.1% ophthalmic solution for dry eye disease. |
|
zolpidem zolpidem |
Almatica Pharma | A new immediate-release capsule for short-term treatment of insomnia. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Makena hydroxyprogesterone caproate Click here for more information |
AMAG Pharmaceuticals | A progestin to reduce the risk of preterm birth. |